Onsdag 29 Oktober | 12:00:19 Europe / Stockholm

Prenumeration

2025-10-27 14:08:00

Redeye retains its positive view of Avensia despite slightly lowering our Base Case and forecasts. The momentum in Commerce remains strong while IM is hurt by meeting a soft market with a cost level that is suited for growth.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/